Richard Harris Martin
Addiction Counselor at Girard, Englewood, CO

License number

Colorado 4530

Issued Date

Apr 15, 1996

Renew Date

Jul 1, 2003

Expiration Date

Jan 16, 2004

Type

Certified Addiction Counselor I

Address

3232 W Girard Ave UNIT A, Englewood, CO 80110

Professional information

See more information about Richard Harris Martin at trustoria.com

Diagnosing Asthma Patients Predisposed To Adverse Beta-Agonist Reactions

US Patent:

2002011, Aug 29, 2002

Filed:

Nov 21, 2001

Appl. No.:

09/990596

Inventors:

Jeffrey Drazen - Winchester MA, US
Vern Chinchilli - Elizabethtown PA, US
Richard Martin - Englewood CO, US
Robert Lemanske - Madison OH, US
Jean Ford - Newark NJ, US
James Fish - Gladwyne PA, US
Homer Boushey - San Francisco CA, US

International Classification:

C12Q001/68, C12P019/34

US Classification:

435/006000, 435/091200

Abstract:

The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of -agonists. The invention also provides kits useful for this purpose.

Diagnosing Asthma Patients Predisposed To Adverse .Beta.-Agonist Reactions

US Patent:

6156503, Dec 5, 2000

Filed:

Mar 3, 1997

Appl. No.:

8/811441

Inventors:

Jeffrey M. Drazen - Winchester MA
Vern Chinchilli - Elizabethtown PA
Richard Martin - Englewood CO
Robert Lemanske - Madison MS
Jean G. Ford - Newark NJ
James E. Fish - Gladwyne PA
Homer Boushey - San Francisco CA

Assignee:

The Regents of the University of California - Oakland CA
The Trustees of Columbia University in the City of New York - New York NY
The Penn State Research Foundation - University Park PA
National Jewish Medical and Research Center - Denver CO
Wisconsin Alumni Research Center - Madison WI
Thomas Jefferson University - Philadelphia PA
Brigham and Women's Hospital - Boston MA

International Classification:

C12Q 168, C07H 2104

US Classification:

435 6

Abstract:

The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of. beta. -agonists. The invention also provides kits useful for this purpose.